16.28 Cr
0.95%
Nifty Healthcare TRI
INF740KA1WD5
100.0
100.0
100
Mr. Anil Ghelani, Mr. Diipesh Shah
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| DSP Nifty Healthcare Index Fund - Regular - IDCW | - | - | - |
| NIFTY Healthcare TRI | 6.34 | 23.23 | 13.52 |
Equity
Debt
Others
The investment objective of the Scheme is to generate returns that are commensurate with the performance of the Nifty Healthcare Index, subject to tracking error. There is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 18.0 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.19 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 7.94 |
| Dr. Reddys Laboratories Ltd | 7.91 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.64 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 7.58 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 5.56 |
| FORTIS HEALTHCARE LIMITED. EQ | 4.73 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.41 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 3.99 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.65 |